Count | |
| 2 | |
| 13 | |
| 2 | |
| 1 | |
| 2 | |
| 14 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
Anti-Retroviral Agents/*administration & dosage/therapeutic use | 1 |
| 2 | |
| 1 | |
Anti-Retroviral Agents/administration & dosage/*therapeutic use | 3 |
Anti-Retroviral Agents/*administration & dosage/adverse effects | 1 |
Anti-Retroviral Agents/adverse effects/*pharmacology/therapeutic use | 1 |
| 2 | |
| 4 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
*Anti-Inflammatory Agents, Non-Steroidal/economics/therapeutic use | 2 |
Anti-HIV Agents/adverse effects/*blood/economics/therapeutic use | 1 |
| 2 | |
| 1 | |
| 1 | |
| 2 | |
| 2 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 5 | |
| 2 | |
| 1 | |
| 45 | |
| 1 | |
| 445 | |
| 1 | |
| 228 | |
| 1 | |
| 4 | |
| 1 | |
| 9 | |
| 4 | |
| 2 | |
| 3 | |
| 2 | |
| 2 | |
| 11 | |
| 3 | |
| 2 | |
| 137 | |
| 1 | |
| 6 | |
| 2 | |
Antihypertensive Agents/classification/*economics/*therapeutic use | 1 |
| 1 | |
Antineoplastic Agents/economics/pharmacokinetics/*therapeutic use | 1 |
| 1 | |
| 16 | |
| 2 | |
| 1 | |
| 1 | |
| 5 | |
| 1 | |
| 12 | |
| 2 | |
| 8 | |
| 20 | |
| 1 | |
| 10 | |
| 2 | |
| 5 | |
| 3 | |
| 2 | |
| 2 | |
| 1 | |
| 3 | |
| 10 | |
| 2 | |
| 66 | |
| 37 | |
| 6 | |
| 1 | |
| 19 | |
| 1 | |
| 6 | |
| 4 | |
| 2 | |